User:Mr. Ibrahem/Pasireotide

Pasireotide, sold under the brand name Signifor, is a medication used to treat Cushing's disease and acromegaly. It is used in Cushing's disease when surgery is not effective, and in acromegaly when neither surgery nor another somatostatin is effective. It is given by injection under the skin or into a muscle.

Common side effects include high blood sugar, diarrhea, abdominal pain, nausea, gallstones, injection site reactions, and tiredness. Other side effects may include low cortisol, slow heart rate, and liver problems. It is a somatostatin analog which blocks the release of growth hormone and cortisol.

Pasireotide was approved in Europe and the United States in 2012. In the United Kingdom it costs the NHS about £2,300 to £3,200 a month as of 2021. In the United States this amount costs about 15,300 USD.